Cellectar Biosciences, Inc. Research and Development Expense
Cellectar Biosciences, Inc. (CLRB) reported Research and Development Expense of $4.56 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:ResearchAndDevelopmentExpense · last filed 2026-08-13
- Cellectar Biosciences, Inc. research and development expense for the quarter ending 2026-06-30 was $4.56M, a 90.70% increase year-over-year.
- Cellectar Biosciences, Inc. research and development expense for the quarter ending 2026-03-31 was $3.01M, a 12.25% decline year-over-year.
- Cellectar Biosciences, Inc. research and development expense for the quarter ending 2025-12-31 was $3.16M, a 49.13% decline year-over-year.
- Cellectar Biosciences, Inc. research and development expense for the quarter ending 2025-09-30 was $2.52M, a 54.07% decline year-over-year.
- Cellectar Biosciences, Inc. research and development expense for fiscal 2025 was $11.50M, a 56.00% decline from fiscal 2024.
- Cellectar Biosciences, Inc. research and development expense for fiscal 2024 was $26.14M, a 4.14% decline from fiscal 2023.
- Cellectar Biosciences, Inc. research and development expense for fiscal 2023 was $27.27M, a 49.28% increase from fiscal 2022.
- Cellectar Biosciences, Inc. research and development expense for fiscal 2022 was $18.27M, a 3.86% increase from fiscal 2021.
| Period end | Research and Development Expense 3 month | Research and Development Expense 3 month as first filed | Research and Development Expense 6 month | Research and Development Expense 6 month as first filed | Research and Development Expense 9 month | Research and Development Expense 9 month as first filed | Research and Development Expense 12 month | Research and Development Expense 12 month as first filed | Research and Development Expense 104 month | Research and Development Expense 107 month | Research and Development Expense 110 month | Research and Development Expense 113 month | Research and Development Expense 116 month | Research and Development Expense 119 month | Research and Development Expense 122 month | Research and Development Expense 125 month | Research and Development Expense 128 month | Research and Development Expense 131 month | Research and Development Expense 134 month | Research and Development Expense 137 month |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $4.56M 10-Q · filed 2026-08-13 | $7.56M 10-Q · filed 2026-08-13 | $10.72M derived: sum of 3 quarters · filed 2026-08-13 | $13.25M derived: sum of 4 quarters · filed 2026-08-13 | ||||||||||||||||
| 2026-03-31 | $3.01M 10-Q · filed 2026-05-14 | $6.17M derived: sum of 2 quarters · filed 2026-05-14 | $8.69M derived: sum of 3 quarters · filed 2026-05-14 | $11.08M derived: sum of 4 quarters · filed 2026-08-13 | ||||||||||||||||
| 2025-12-31 | $3.16M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-04 | $5.68M derived: sum of 2 quarters · filed 2026-03-04 | $8.07M derived: sum of 3 quarters · filed 2026-08-13 | $11.50M 10-K · filed 2026-03-04 | ||||||||||||||||
| 2025-09-30 | $2.52M 10-Q · filed 2025-11-13 | $4.91M derived: sum of 2 quarters · filed 2026-08-13 | $8.34M 10-Q · filed 2025-11-13 | $14.55M derived: sum of 4 quarters · filed 2026-08-13 | ||||||||||||||||
| 2025-06-30 | $2.39M 10-Q · filed 2026-08-13 | $5.82M 10-Q · filed 2026-08-13 | $12.03M derived: sum of 3 quarters · filed 2026-08-13 | $17.52M derived: sum of 4 quarters · filed 2026-08-13 | ||||||||||||||||
| 2025-03-31 | $3.43M 10-Q · filed 2026-05-14 | $9.64M derived: sum of 2 quarters · filed 2026-05-14 | $15.13M derived: sum of 3 quarters · filed 2026-05-14 | $22.48M derived: sum of 4 quarters · filed 2026-05-14 | ||||||||||||||||
| 2024-12-31 | $6.21M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-04 | $11.70M derived: sum of 2 quarters · filed 2026-03-04 | $19.05M derived: sum of 3 quarters · filed 2026-03-04 | $26.14M 10-K · filed 2026-03-04 | ||||||||||||||||
| 2024-09-30 | $5.49M 10-Q · filed 2025-11-13 | $12.84M derived: sum of 2 quarters · filed 2025-11-13 | $19.93M 10-Q · filed 2025-11-13 | $27.66M derived: sum of 4 quarters · filed 2025-11-13 | ||||||||||||||||
| 2024-06-30 | $7.35M 10-Q · filed 2025-08-14 | $14.43M 10-Q · filed 2025-08-14 | $22.17M derived: sum of 3 quarters · filed 2025-08-14 | $29.21M derived: sum of 4 quarters · filed 2025-08-14 | ||||||||||||||||
| 2024-03-31 | $7.09M 10-Q · filed 2025-05-13 | $7.38M 10-Q · filed 2024-05-14 | $14.83M derived: sum of 2 quarters · filed 2025-05-13 | $21.86M derived: sum of 3 quarters · filed 2025-05-13 | $28.00M derived: sum of 4 quarters · filed 2025-05-13 | |||||||||||||||
| 2023-12-31 | $7.74M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-13 | $14.77M derived: sum of 2 quarters · filed 2025-03-13 | $20.91M derived: sum of 3 quarters · filed 2025-03-13 | $27.27M 10-K · filed 2025-03-13 | $28.21M 10-K · filed 2024-03-27 | |||||||||||||||
| 2023-09-30 | $7.03M 10-Q · filed 2024-11-18 | $7.31M 10-Q · filed 2023-11-13 | $13.17M derived: sum of 2 quarters · filed 2024-11-18 | $19.53M 10-Q · filed 2024-11-18 | $20.28M 10-Q · filed 2023-11-13 | $24.03M derived: sum of 4 quarters · filed 2024-11-18 | ||||||||||||||
| 2023-06-30 | $6.14M 10-K/A · filed 2024-10-29 | $6.31M 10-Q · filed 2023-08-14 | $12.49M 10-K/A · filed 2024-10-29 | $12.96M 10-Q · filed 2023-08-14 | $16.99M derived: sum of 3 quarters · filed 2024-10-29 | $22.20M derived: sum of 4 quarters · filed 2024-10-29 | ||||||||||||||
| 2023-03-31 | $6.36M 10-K/A · filed 2024-10-29 | $6.65M 10-Q · filed 2023-05-04 | $10.86M derived: sum of 2 quarters · filed 2024-10-29 | $16.07M derived: sum of 3 quarters · filed 2024-10-29 | $20.21M derived: sum of 4 quarters · filed 2024-10-29 | |||||||||||||||
| 2022-12-31 | $4.50M derived: 10-K/A 12 month − 10-Q 9 month · filed 2024-10-29 | $9.71M derived: sum of 2 quarters · filed 2024-10-29 | $13.86M derived: sum of 3 quarters · filed 2024-10-29 | $18.27M 10-K/A · filed 2024-10-29 | $19.22M 10-K · filed 2023-03-09 | |||||||||||||||
| 2022-09-30 | $5.21M 10-K/A · filed 2024-10-29 | $5.38M 10-Q · filed 2022-11-03 | $9.36M derived: sum of 2 quarters · filed 2024-10-29 | $13.77M 10-Q · filed 2023-11-13 | $17.45M derived: sum of 4 quarters · filed 2024-10-29 | |||||||||||||||
| 2022-06-30 | $4.14M 10-K/A · filed 2024-10-29 | $4.50M 10-Q · filed 2022-08-05 | $8.39M 10-Q · filed 2023-08-14 | $12.24M derived: sum of 3 quarters · filed 2024-10-29 | $16.17M derived: sum of 4 quarters · filed 2024-10-29 | |||||||||||||||
| 2022-03-31 | $3.70M 10-K/A · filed 2024-10-29 | $3.89M 10-Q · filed 2022-05-10 | $8.09M derived: sum of 2 quarters · filed 2024-10-29 | $12.03M derived: sum of 3 quarters · filed 2024-10-29 | $16.66M derived: sum of 4 quarters · filed 2024-10-29 | |||||||||||||||
| 2021-12-31 | $4.39M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-09 | $8.33M derived: sum of 2 quarters · filed 2023-03-09 | $12.95M derived: sum of 3 quarters · filed 2023-03-09 | $17.59M 10-K · filed 2023-03-09 | ||||||||||||||||
| 2021-09-30 | $3.94M 10-Q · filed 2022-11-03 | $8.57M derived: sum of 2 quarters · filed 2022-11-03 | $13.20M 10-Q · filed 2022-11-03 | $15.57M derived: sum of 4 quarters · filed 2022-11-03 | ||||||||||||||||
| 2021-06-30 | $4.63M 10-Q · filed 2022-08-05 | $9.26M 10-Q · filed 2022-08-05 | $11.64M derived: sum of 3 quarters · filed 2022-08-05 | $14.32M derived: sum of 4 quarters · filed 2022-08-05 | ||||||||||||||||
| 2021-03-31 | $4.63M 10-Q · filed 2022-05-10 | $7.01M derived: sum of 2 quarters · filed 2022-05-10 | $9.69M derived: sum of 3 quarters · filed 2022-05-10 | $12.16M derived: sum of 4 quarters · filed 2022-05-10 | ||||||||||||||||
| 2020-12-31 | $2.38M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-21 | $5.06M derived: sum of 2 quarters · filed 2022-03-21 | $7.52M derived: sum of 3 quarters · filed 2022-03-21 | $10.14M 10-K · filed 2022-03-21 | ||||||||||||||||
| 2020-09-30 | $2.68M 10-Q · filed 2021-11-08 | $5.15M derived: sum of 2 quarters · filed 2021-11-08 | $7.77M 10-Q · filed 2021-11-08 | $9.94M derived: sum of 4 quarters · filed 2021-11-08 | ||||||||||||||||
| 2020-06-30 | $2.47M 10-Q · filed 2021-08-09 | $5.08M 10-Q · filed 2021-08-09 | $7.26M derived: sum of 3 quarters · filed 2021-08-09 | $9.96M derived: sum of 4 quarters · filed 2021-08-09 | ||||||||||||||||
| 2020-03-31 | $2.62M 10-Q · filed 2021-05-10 | $4.79M derived: sum of 2 quarters · filed 2021-05-10 | $7.49M derived: sum of 3 quarters · filed 2021-05-10 | $9.30M derived: sum of 4 quarters · filed 2021-05-10 | ||||||||||||||||
| 2019-12-31 | $2.17M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-02 | $4.88M derived: sum of 2 quarters · filed 2021-03-02 | $6.69M derived: sum of 3 quarters · filed 2021-03-02 | $9.00M 10-K · filed 2021-03-02 | ||||||||||||||||
| 2019-09-30 | $2.70M 10-Q · filed 2020-11-09 | $4.51M derived: sum of 2 quarters · filed 2020-11-09 | $6.82M 10-Q · filed 2020-11-09 | $7.86M derived: sum of 4 quarters · filed 2020-11-09 | ||||||||||||||||
| 2019-06-30 | $1.81M 10-Q · filed 2020-08-10 | $4.12M 10-Q · filed 2020-08-10 | $5.15M derived: sum of 3 quarters · filed 2020-08-10 | $7.15M derived: sum of 4 quarters · filed 2020-08-10 | ||||||||||||||||
| 2019-03-31 | $2.31M 10-Q · filed 2020-05-07 | $3.35M derived: sum of 2 quarters · filed 2020-05-07 | $5.34M derived: sum of 3 quarters · filed 2020-05-07 | $7.06M derived: sum of 4 quarters · filed 2020-05-07 | ||||||||||||||||
| 2018-12-31 | $1.04M derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-09 | $3.03M derived: sum of 2 quarters · filed 2020-03-09 | $4.76M derived: sum of 3 quarters · filed 2020-03-09 | $6.84M 10-K · filed 2020-03-09 | ||||||||||||||||
| 2018-09-30 | $2.00M 10-Q · filed 2019-11-12 | $3.72M derived: sum of 2 quarters · filed 2019-11-12 | $5.80M 10-Q · filed 2019-11-12 | $8.94M derived: sum of 4 quarters · filed 2019-11-12 | ||||||||||||||||
| 2018-06-30 | $1.72M 10-Q · filed 2019-08-12 | $3.80M 10-Q · filed 2019-08-12 | $6.95M derived: sum of 3 quarters · filed 2019-08-12 | $9.28M derived: sum of 4 quarters · filed 2019-08-12 | ||||||||||||||||
| 2018-03-31 | $2.12M 10-Q · filed 2019-05-06 | $5.22M derived: sum of 2 quarters · filed 2019-05-06 | $7.56M derived: sum of 3 quarters · filed 2019-05-06 | $9.73M derived: sum of 4 quarters · filed 2019-05-06 | ||||||||||||||||
| 2017-12-31 | $3.10M derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-26 | $5.43M derived: sum of 2 quarters · filed 2019-02-26 | $7.61M derived: sum of 3 quarters · filed 2019-02-26 | $9.47M 10-K · filed 2019-02-26 | ||||||||||||||||
| 2017-09-30 | $2.33M 10-Q · filed 2018-11-13 | $4.51M derived: sum of 2 quarters · filed 2018-11-13 | $6.37M 10-Q · filed 2018-11-13 | $7.81M derived: sum of 4 quarters · filed 2018-11-13 | ||||||||||||||||
| 2017-06-30 | $2.18M 10-Q · filed 2018-08-10 | $4.03M 10-Q · filed 2018-08-10 | $5.47M derived: sum of 3 quarters · filed 2018-08-10 | $6.78M derived: sum of 4 quarters · filed 2018-08-10 | ||||||||||||||||
| 2017-03-31 | $1.86M 10-Q · filed 2018-05-11 | $3.30M derived: sum of 2 quarters · filed 2018-05-11 | $4.60M derived: sum of 3 quarters · filed 2018-05-11 | $5.57M derived: sum of 4 quarters · filed 2018-05-11 | ||||||||||||||||
| 2016-12-31 | $1.44M derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-21 | $2.75M derived: sum of 2 quarters · filed 2018-03-21 | $3.71M derived: sum of 3 quarters · filed 2018-03-21 | $4.75M 10-K · filed 2018-03-21 | ||||||||||||||||
| 2016-09-30 | $1.31M 10-Q · filed 2017-11-09 | $2.27M derived: sum of 2 quarters · filed 2017-11-09 | $3.31M 10-Q · filed 2017-11-09 | $4.27M derived: sum of 4 quarters · filed 2017-11-09 | ||||||||||||||||
| 2016-06-30 | $965.18K 10-Q · filed 2017-08-14 | $2.00M 10-Q · filed 2017-08-14 | $2.97M derived: sum of 3 quarters · filed 2017-08-14 | $4.14M derived: sum of 4 quarters · filed 2017-08-14 | ||||||||||||||||
| 2016-03-31 | $1.04M 10-Q · filed 2017-05-11 | $2.00M derived: sum of 2 quarters · filed 2017-05-11 | $3.17M derived: sum of 3 quarters · filed 2017-05-11 | $4.55M derived: sum of 4 quarters · filed 2017-05-11 | ||||||||||||||||
| 2015-12-31 | $964.15K derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-15 | $2.13M derived: sum of 2 quarters · filed 2017-03-15 | $3.51M derived: sum of 3 quarters · filed 2017-03-15 | $5.16M 10-K · filed 2017-03-15 | ||||||||||||||||
| 2015-09-30 | $1.17M 10-Q · filed 2016-11-10 | $2.55M derived: sum of 2 quarters · filed 2016-11-10 | $4.19M 10-Q · filed 2016-11-10 | $5.59M derived: sum of 4 quarters · filed 2016-11-10 | ||||||||||||||||
| 2015-06-30 | $1.38M 10-Q · filed 2016-08-11 | $3.03M 10-Q · filed 2016-08-11 | $4.43M derived: sum of 3 quarters · filed 2016-10-20 | $5.90M derived: sum of 4 quarters · filed 2016-10-20 | ||||||||||||||||
| 2015-03-31 | $1.64M 10-Q · filed 2016-05-12 | $3.04M derived: sum of 2 quarters · filed 2016-10-20 | $4.51M derived: sum of 3 quarters · filed 2016-10-20 | $5.89M derived: sum of 4 quarters · filed 2016-10-20 | ||||||||||||||||
| 2014-12-31 | $1.40M derived: 10-K/A 12 month − 10-Q 9 month · filed 2016-10-20 | $2.87M derived: sum of 2 quarters · filed 2016-10-20 | $4.25M derived: sum of 3 quarters · filed 2016-10-20 | $5.96M 10-K/A · filed 2016-10-20 | ||||||||||||||||
| 2014-09-30 | $1.47M 10-Q · filed 2015-11-12 | $2.85M derived: sum of 2 quarters · filed 2015-11-12 | $4.57M 10-Q · filed 2015-11-12 | $6.12M derived: sum of 4 quarters · filed 2015-11-12 | ||||||||||||||||
| 2014-06-30 | $1.38M 10-Q · filed 2015-08-12 | $3.10M 10-Q · filed 2015-08-12 | $4.65M derived: sum of 3 quarters · filed 2015-08-12 | $6.72M derived: sum of 4 quarters · filed 2015-08-12 | ||||||||||||||||
| 2014-03-31 | $1.72M 10-Q · filed 2015-05-20 | $3.27M derived: sum of 2 quarters · filed 2015-05-20 | $5.34M derived: sum of 3 quarters · filed 2015-05-20 | $6.98M derived: sum of 4 quarters · filed 2015-05-20 | $34.50M 10-Q · filed 2014-05-14 | |||||||||||||||
| 2013-12-31 | $1.55M derived: 10-K 12 month − 10-Q 9 month · filed 2015-05-20 | $3.62M derived: sum of 2 quarters · filed 2015-05-20 | $5.27M derived: sum of 3 quarters · filed 2015-05-20 | $6.86M 10-K · filed 2015-05-20 | $32.79M 10-K · filed 2014-03-19 | |||||||||||||||
| 2013-09-30 | $2.07M 10-Q · filed 2015-05-20 | $3.72M derived: sum of 2 quarters · filed 2015-05-20 | $5.31M 10-Q · filed 2015-05-20 | $6.53M derived: sum of 4 quarters · filed 2015-05-20 | $31.23M 10-Q · filed 2013-11-13 | |||||||||||||||
| 2013-06-30 | $1.65M 10-Q · filed 2014-08-04 | $3.24M 10-Q · filed 2014-08-04 | $4.47M derived: sum of 3 quarters · filed 2014-08-04 | $5.72M derived: sum of 4 quarters · filed 2014-08-04 | $29.17M 10-Q · filed 2013-08-12 | |||||||||||||||
| 2013-03-31 | $1.59M 10-Q · filed 2014-05-14 | $2.82M derived: sum of 2 quarters · filed 2014-05-14 | $4.07M derived: sum of 3 quarters · filed 2014-05-14 | $5.38M derived: sum of 4 quarters · filed 2014-05-14 | $27.52M 10-Q · filed 2013-05-15 | |||||||||||||||
| 2012-12-31 | $1.23M derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-19 | $2.48M derived: sum of 2 quarters · filed 2014-03-19 | $3.79M derived: sum of 3 quarters · filed 2014-03-19 | $5.12M 10-K · filed 2014-03-19 | $25.93M 10-K · filed 2013-03-28 | |||||||||||||||
| 2012-09-30 | $1.25M 10-Q · filed 2013-11-13 | $2.57M derived: sum of 2 quarters · filed 2013-11-13 | $3.90M 10-Q · filed 2013-11-13 | $5.05M derived: sum of 4 quarters · filed 2013-11-13 | $24.70M 10-Q · filed 2012-11-06 | |||||||||||||||
| 2012-06-30 | $1.31M 10-Q · filed 2013-08-12 | $2.64M 10-Q · filed 2013-08-12 | $3.80M derived: sum of 3 quarters · filed 2013-08-12 | $4.80M derived: sum of 4 quarters · filed 2013-08-12 | $23.45M 10-Q · filed 2012-08-09 | |||||||||||||||
| 2012-03-31 | $1.33M 10-Q · filed 2013-05-15 | $2.48M derived: sum of 2 quarters · filed 2013-05-15 | $3.49M derived: sum of 3 quarters · filed 2013-05-15 | $4.45M derived: sum of 4 quarters · filed 2013-05-15 | $22.13M 10-Q · filed 2012-05-04 | |||||||||||||||
| 2011-12-31 | $1.15M derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-28 | $2.16M derived: sum of 2 quarters · filed 2013-03-28 | $3.12M derived: sum of 3 quarters · filed 2013-03-28 | $3.60M 10-K · filed 2013-03-28 | $20.81M 10-K · filed 2012-03-09 | |||||||||||||||
| 2011-09-30 | $1.01M 10-Q · filed 2012-11-06 | $1.97M derived: sum of 2 quarters · filed 2012-11-06 | $2.45M 10-Q · filed 2012-11-06 | $2.81M derived: sum of 4 quarters · filed 2012-11-06 | $19.65M 10-Q · filed 2011-11-07 | |||||||||||||||
| 2011-06-30 | $961.95K 10-Q · filed 2012-08-09 | $1.43M 10-Q · filed 2012-08-09 | $1.80M derived: sum of 3 quarters · filed 2012-08-09 | $2.30M derived: sum of 4 quarters · filed 2012-08-09 | $18.64M 10-Q · filed 2011-08-12 | |||||||||||||||
| 2011-03-31 | $471.40K 10-Q · filed 2012-05-04 | $838.78K derived: sum of 2 quarters · filed 2012-05-04 | $1.34M derived: sum of 3 quarters · filed 2012-05-04 | $2.30M derived: sum of 4 quarters · filed 2012-05-04 | ||||||||||||||||
| 2010-12-31 | $367.37K derived: 10-K 12 month − 10-Q 9 month · filed 2012-03-09 | $867.54K derived: sum of 2 quarters · filed 2012-03-09 | $1.83M derived: sum of 3 quarters · filed 2012-03-09 | $2.98M 10-K · filed 2012-03-09 | ||||||||||||||||
| 2010-09-30 | $500.17K 10-Q · filed 2011-11-07 | $1.46M derived: sum of 2 quarters · filed 2011-11-07 | $2.62M 10-Q · filed 2011-11-07 | |||||||||||||||||
| 2010-06-30 | $963.14K 10-Q · filed 2011-08-12 | $2.10M 10-Q · filed 2011-08-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Marker Therapeutics, Inc. (MRKR) | United States | $0.020B | -2.86 |
| Neuphoria Therapeutics Inc. (NEUP) | United States | $0.020B | -1.77 |
| Shuttle Pharmaceuticals Holdings, Inc. (SHPH) | United States | $0.019B | -0.31 |
| Rocket One Inc. (RKTO) | United States | $0.019B | |
| ATOSSA THERAPEUTICS, INC. (ATOS) | United States | $0.021B | -0.52 |
| Biofrontera Inc. (BFRI) | United States | $0.018B | -2.13 |
| Lipocine Inc. (LPCN) | United States | $0.017B | -1.79 |
| Cocrystal Pharma, Inc. (COCP) | United States | $0.022B | |
| PALATIN TECHNOLOGIES INC (PTN) | United States | $0.017B | -5.36 |
| Allarity Therapeutics, Inc. (ALLR) | United States | $0.017B | -1.66 |